APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chronic Venous Insufficiency

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Chronic Venous Insufficiency Industry Growth and Trends Forecast to 2032

24 December 2025121 pages

Choose your research edition.

Industry ResearchChronic Venous Insufficiency Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Venous Insufficiency Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Chronic Venous Insufficiency Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Venous Insufficiency Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Venous Insufficiency Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

According to APO Research, the global Chronic Venous Insufficiency market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Chronic Venous Insufficiency is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Chronic Venous Insufficiency is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Venous Insufficiency is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Chronic Venous Insufficiency market include Suzhou Yinluo Medical Devices, Suzhou Tianhong Shengjie Medical Devices, Shanghai Lanmai Medical Technology, Shanghai Ensheng Medical Technology, Hangzhou Weiqiang Medical Technology, Zylox-Tonbridge Medical Technology, Teva, Sun Pharma and Philips, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Chronic Venous Insufficiency market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Chronic Venous Insufficiency market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chronic Venous Insufficiency market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chronic Venous Insufficiency.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Chronic Venous Insufficiency market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Chronic Venous Insufficiency Market by Company

Suzhou Yinluo Medical Devices

Suzhou Tianhong Shengjie Medical Devices

Shanghai Lanmai Medical Technology

Shanghai Ensheng Medical Technology

Hangzhou Weiqiang Medical Technology

Zylox-Tonbridge Medical Technology

Teva

Sun Pharma

Philips

Pfizer

optimed Medizinische Instrumente

Mylan

Medtronic

Cook Ireland

Boston Scientific

BD(Angiomed)

Allergan

AbbVie

Abbott

3M

Chronic Venous Insufficiency Segment by Type

Medical Equipment and Consumables

Drugs

Chronic Venous Insufficiency Segment by Application

Hospital

Clinic

Other

Chronic Venous Insufficiency Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Venous Insufficiency market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Venous Insufficiency and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Venous Insufficiency.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Chronic Venous Insufficiency companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Chronic Venous Insufficiency Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Chronic Venous Insufficiency Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Chronic Venous Insufficiency Market Share by Region (2021-2026) Table 4. Global Chronic Venous Insufficiency Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Chronic Venous Insufficiency Market Share by Region (2027-2032) Table 6. Global Chronic Venous Insufficiency Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Chronic Venous Insufficiency Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Chronic Venous Insufficiency Market Size Share by Type (2021-2026) Table 9. Global Chronic Venous Insufficiency Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Chronic Venous Insufficiency Market Size Share Forecasted by Type (2027-2032) Table 11. North America Chronic Venous Insufficiency Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Chronic Venous Insufficiency Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Chronic Venous Insufficiency Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Chronic Venous Insufficiency Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Chronic Venous Insufficiency Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Chronic Venous Insufficiency Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Chronic Venous Insufficiency Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Chronic Venous Insufficiency Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Chronic Venous Insufficiency Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Chronic Venous Insufficiency Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Chronic Venous Insufficiency Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Chronic Venous Insufficiency Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Chronic Venous Insufficiency Market Size Share by Application (2021-2026) Table 24. Global Chronic Venous Insufficiency Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Chronic Venous Insufficiency Market Size Share Forecasted by Application (2027-2032) Table 26. North America Chronic Venous Insufficiency Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Chronic Venous Insufficiency Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Chronic Venous Insufficiency Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Chronic Venous Insufficiency Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Chronic Venous Insufficiency Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Chronic Venous Insufficiency Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Chronic Venous Insufficiency Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Chronic Venous Insufficiency Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Chronic Venous Insufficiency Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Chronic Venous Insufficiency Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Chronic Venous Insufficiency Industry Trends Table 37. Chronic Venous Insufficiency Industry Drivers Table 38. Chronic Venous Insufficiency Industry Opportunities and Challenges Table 39. Chronic Venous Insufficiency Industry Restraints Table 40. Global Chronic Venous Insufficiency Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Chronic Venous Insufficiency Revenue Market Share by Company (2021-2026) Table 42. Global Chronic Venous Insufficiency Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Chronic Venous Insufficiency Key Company Headquarters & Area Served Table 44. Global Chronic Venous Insufficiency Company, Product Type & Application Table 45. Global Chronic Venous Insufficiency Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Chronic Venous Insufficiency by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Suzhou Yinluo Medical Devices Company Information Table 49. Suzhou Yinluo Medical Devices Business Overview Table 50. Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Product Portfolio Table 52. Suzhou Yinluo Medical Devices Recent Development Table 53. Suzhou Tianhong Shengjie Medical Devices Company Information Table 54. Suzhou Tianhong Shengjie Medical Devices Business Overview Table 55. Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Product Portfolio Table 57. Suzhou Tianhong Shengjie Medical Devices Recent Development Table 58. Shanghai Lanmai Medical Technology Company Information Table 59. Shanghai Lanmai Medical Technology Business Overview Table 60. Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Product Portfolio Table 62. Shanghai Lanmai Medical Technology Recent Development Table 63. Shanghai Ensheng Medical Technology Company Information Table 64. Shanghai Ensheng Medical Technology Business Overview Table 65. Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Product Portfolio Table 67. Shanghai Ensheng Medical Technology Recent Development Table 68. Hangzhou Weiqiang Medical Technology Company Information Table 69. Hangzhou Weiqiang Medical Technology Business Overview Table 70. Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Product Portfolio Table 72. Hangzhou Weiqiang Medical Technology Recent Development Table 73. Zylox-Tonbridge Medical Technology Company Information Table 74. Zylox-Tonbridge Medical Technology Business Overview Table 75. Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Product Portfolio Table 77. Zylox-Tonbridge Medical Technology Recent Development Table 78. Teva Company Information Table 79. Teva Business Overview Table 80. Teva Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Teva Chronic Venous Insufficiency Product Portfolio Table 82. Teva Recent Development Table 83. Sun Pharma Company Information Table 84. Sun Pharma Business Overview Table 85. Sun Pharma Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Sun Pharma Chronic Venous Insufficiency Product Portfolio Table 87. Sun Pharma Recent Development Table 88. Philips Company Information Table 89. Philips Business Overview Table 90. Philips Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Philips Chronic Venous Insufficiency Product Portfolio Table 92. Philips Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Pfizer Chronic Venous Insufficiency Product Portfolio Table 97. Pfizer Recent Development Table 98. optimed Medizinische Instrumente Company Information Table 99. optimed Medizinische Instrumente Business Overview Table 100. optimed Medizinische Instrumente Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. optimed Medizinische Instrumente Chronic Venous Insufficiency Product Portfolio Table 102. optimed Medizinische Instrumente Recent Development Table 103. Mylan Company Information Table 104. Mylan Business Overview Table 105. Mylan Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Mylan Chronic Venous Insufficiency Product Portfolio Table 107. Mylan Recent Development Table 108. Medtronic Company Information Table 109. Medtronic Business Overview Table 110. Medtronic Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Medtronic Chronic Venous Insufficiency Product Portfolio Table 112. Medtronic Recent Development Table 113. Cook Ireland Company Information Table 114. Cook Ireland Business Overview Table 115. Cook Ireland Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Cook Ireland Chronic Venous Insufficiency Product Portfolio Table 117. Cook Ireland Recent Development Table 118. Boston Scientific Company Information Table 119. Boston Scientific Business Overview Table 120. Boston Scientific Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Boston Scientific Chronic Venous Insufficiency Product Portfolio Table 122. Boston Scientific Recent Development Table 123. BD(Angiomed) Company Information Table 124. BD(Angiomed) Business Overview Table 125. BD(Angiomed) Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. BD(Angiomed) Chronic Venous Insufficiency Product Portfolio Table 127. BD(Angiomed) Recent Development Table 128. Allergan Company Information Table 129. Allergan Business Overview Table 130. Allergan Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Allergan Chronic Venous Insufficiency Product Portfolio Table 132. Allergan Recent Development Table 133. AbbVie Company Information Table 134. AbbVie Business Overview Table 135. AbbVie Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. AbbVie Chronic Venous Insufficiency Product Portfolio Table 137. AbbVie Recent Development Table 138. Abbott Company Information Table 139. Abbott Business Overview Table 140. Abbott Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Abbott Chronic Venous Insufficiency Product Portfolio Table 142. Abbott Recent Development Table 143. 3M Company Information Table 144. 3M Business Overview Table 145. 3M Chronic Venous Insufficiency Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. 3M Chronic Venous Insufficiency Product Portfolio Table 147. 3M Recent Development Table 148. North America Chronic Venous Insufficiency Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Chronic Venous Insufficiency Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Chronic Venous Insufficiency Market Share by Country (2021-2026) Table 151. North America Chronic Venous Insufficiency Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Chronic Venous Insufficiency Market Share Forecast by Country (2027-2032) Table 153. Europe Chronic Venous Insufficiency Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Chronic Venous Insufficiency Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Chronic Venous Insufficiency Market Share by Country (2021-2026) Table 156. Europe Chronic Venous Insufficiency Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Chronic Venous Insufficiency Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Chronic Venous Insufficiency Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Chronic Venous Insufficiency Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Chronic Venous Insufficiency Market Share by Country (2021-2026) Table 161. Asia-Pacific Chronic Venous Insufficiency Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Chronic Venous Insufficiency Market Share Forecast by Country (2027-2032) Table 163. Latin America Chronic Venous Insufficiency Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Chronic Venous Insufficiency Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Chronic Venous Insufficiency Market Share by Country (2021-2026) Table 166. Latin America Chronic Venous Insufficiency Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Chronic Venous Insufficiency Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Chronic Venous Insufficiency Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Chronic Venous Insufficiency Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Chronic Venous Insufficiency Market Share by Country (2021-2026) Table 171. Middle East & Africa Chronic Venous Insufficiency Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Chronic Venous Insufficiency Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Chronic Venous Insufficiency Product Image Figure 3. Global Chronic Venous Insufficiency Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 5. Global Chronic Venous Insufficiency Market Share by Region: 2025 VS 2032 Figure 6. Global Chronic Venous Insufficiency Market Share by Region (2021-2032) Figure 7. North America Chronic Venous Insufficiency Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Chronic Venous Insufficiency Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Chronic Venous Insufficiency Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Chronic Venous Insufficiency Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Chronic Venous Insufficiency Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Medical Equipment and Consumables Image Figure 13. Global Medical Equipment and Consumables Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Drugs Image Figure 15. Global Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Chronic Venous Insufficiency Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Chronic Venous Insufficiency Market Share by Type 2025 VS 2032 Figure 18. North America Chronic Venous Insufficiency Market Size Share by Type (2021-2032) Figure 19. Europe Chronic Venous Insufficiency Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Chronic Venous Insufficiency Market Size Share by Type (2021-2032) Figure 21. Latin America Chronic Venous Insufficiency Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Chronic Venous Insufficiency Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Clinic Image Figure 26. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Other Image Figure 28. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Chronic Venous Insufficiency Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Chronic Venous Insufficiency Market Share by Application 2025 VS 2032 Figure 31. North America Chronic Venous Insufficiency Market Size Share by Application (2021-2032) Figure 32. Europe Chronic Venous Insufficiency Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Chronic Venous Insufficiency Market Size Share by Application (2021-2032) Figure 34. Latin America Chronic Venous Insufficiency Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Chronic Venous Insufficiency Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Chronic Venous Insufficiency Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Chronic Venous Insufficiency Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Chronic Venous Insufficiency Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Chronic Venous Insufficiency Market Share by Country (2021-2032) Figure 41. Europe Chronic Venous Insufficiency Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Chronic Venous Insufficiency Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Chronic Venous Insufficiency Market Share by Country (2021-2032) Figure 44. Asia-Pacific Chronic Venous Insufficiency Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Chronic Venous Insufficiency Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Chronic Venous Insufficiency Market Share by Country (2021-2032) Figure 47. Latin America Chronic Venous Insufficiency Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Chronic Venous Insufficiency Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Chronic Venous Insufficiency Market Share by Country (2021-2032) Figure 50. Middle East & Africa Chronic Venous Insufficiency Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Chronic Venous Insufficiency Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Chronic Venous Insufficiency Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Medical Equipment and Consumables
  • Drugs
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Suzhou Yinluo Medical Devices
  • Suzhou Tianhong Shengjie Medical Devices
  • Shanghai Lanmai Medical Technology
  • Shanghai Ensheng Medical Technology
  • Hangzhou Weiqiang Medical Technology
  • Zylox-Tonbridge Medical Technology
  • Teva
  • Sun Pharma
  • Philips
  • Pfizer
  • optimed Medizinische Instrumente
  • Mylan
  • Medtronic
  • Cook Ireland
  • Boston Scientific
  • BD(Angiomed)
  • Allergan
  • AbbVie
  • Abbott
  • 3M

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Chronic Venous Insufficiency Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Chronic Venous Insufficiency Market Size by Region (2021-2032)
  5. 1.4.1 Global Chronic Venous Insufficiency Market Size by Region (2021-2026)
  6. 1.4.2 Global Chronic Venous Insufficiency Market Size by Region (2027-2032)
  7. 1.5 Key Regions Chronic Venous Insufficiency Market Size (2021-2032)
  8. 1.5.1 North America Chronic Venous Insufficiency Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Chronic Venous Insufficiency Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Chronic Venous Insufficiency Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Chronic Venous Insufficiency Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Chronic Venous Insufficiency Market Size Growth Rate (2021-2032)
2 Chronic Venous Insufficiency Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Medical Equipment and Consumables
  3. 2.1.2 Drugs
  4. 2.2 Global Chronic Venous Insufficiency Market Size by Type
  5. 2.2.1 Global Chronic Venous Insufficiency Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Chronic Venous Insufficiency Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Chronic Venous Insufficiency Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Chronic Venous Insufficiency Market Size by Regions
  9. 2.3.1 North America Chronic Venous Insufficiency Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Chronic Venous Insufficiency Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Chronic Venous Insufficiency Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Chronic Venous Insufficiency Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Chronic Venous Insufficiency Market Size Breakdown by Type (2021-2026)
3 Chronic Venous Insufficiency Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Other
  5. 3.2 Global Chronic Venous Insufficiency Market Size by Application
  6. 3.2.1 Global Chronic Venous Insufficiency Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Chronic Venous Insufficiency Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Chronic Venous Insufficiency Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Chronic Venous Insufficiency Market Size by Regions
  10. 3.3.1 North America Chronic Venous Insufficiency Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Chronic Venous Insufficiency Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Chronic Venous Insufficiency Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Chronic Venous Insufficiency Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Chronic Venous Insufficiency Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Chronic Venous Insufficiency Industry Trends
  2. 4.2 Chronic Venous Insufficiency Industry Drivers
  3. 4.3 Chronic Venous Insufficiency Industry Opportunities and Challenges
  4. 4.4 Chronic Venous Insufficiency Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Chronic Venous Insufficiency Revenue (2021-2026)
  2. 5.2 Global Chronic Venous Insufficiency Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Chronic Venous Insufficiency Key Company Headquarters & Area Served
  4. 5.4 Global Chronic Venous Insufficiency Company, Product Type & Application
  5. 5.5 Global Chronic Venous Insufficiency Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Chronic Venous Insufficiency Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Chronic Venous Insufficiency Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Chronic Venous Insufficiency Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Suzhou Yinluo Medical Devices
  2. 6.1.1 Suzhou Yinluo Medical Devices Company Information
  3. 6.1.2 Suzhou Yinluo Medical Devices Business Overview
  4. 6.1.3 Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Product Portfolio
  6. 6.1.5 Suzhou Yinluo Medical Devices Recent Developments
  7. 6.2 Suzhou Tianhong Shengjie Medical Devices
  8. 6.2.1 Suzhou Tianhong Shengjie Medical Devices Company Information
  9. 6.2.2 Suzhou Tianhong Shengjie Medical Devices Business Overview
  10. 6.2.3 Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Product Portfolio
  12. 6.2.5 Suzhou Tianhong Shengjie Medical Devices Recent Developments
  13. 6.3 Shanghai Lanmai Medical Technology
  14. 6.3.1 Shanghai Lanmai Medical Technology Company Information
  15. 6.3.2 Shanghai Lanmai Medical Technology Business Overview
  16. 6.3.3 Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Product Portfolio
  18. 6.3.5 Shanghai Lanmai Medical Technology Recent Developments
  19. 6.4 Shanghai Ensheng Medical Technology
  20. 6.4.1 Shanghai Ensheng Medical Technology Company Information
  21. 6.4.2 Shanghai Ensheng Medical Technology Business Overview
  22. 6.4.3 Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Product Portfolio
  24. 6.4.5 Shanghai Ensheng Medical Technology Recent Developments
  25. 6.5 Hangzhou Weiqiang Medical Technology
  26. 6.5.1 Hangzhou Weiqiang Medical Technology Company Information
  27. 6.5.2 Hangzhou Weiqiang Medical Technology Business Overview
  28. 6.5.3 Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Product Portfolio
  30. 6.5.5 Hangzhou Weiqiang Medical Technology Recent Developments
  31. 6.6 Zylox-Tonbridge Medical Technology
  32. 6.6.1 Zylox-Tonbridge Medical Technology Company Information
  33. 6.6.2 Zylox-Tonbridge Medical Technology Business Overview
  34. 6.6.3 Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Product Portfolio
  36. 6.6.5 Zylox-Tonbridge Medical Technology Recent Developments
  37. 6.7 Teva
  38. 6.7.1 Teva Company Information
  39. 6.7.2 Teva Business Overview
  40. 6.7.3 Teva Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Teva Chronic Venous Insufficiency Product Portfolio
  42. 6.7.5 Teva Recent Developments
  43. 6.8 Sun Pharma
  44. 6.8.1 Sun Pharma Company Information
  45. 6.8.2 Sun Pharma Business Overview
  46. 6.8.3 Sun Pharma Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Sun Pharma Chronic Venous Insufficiency Product Portfolio
  48. 6.8.5 Sun Pharma Recent Developments
  49. 6.9 Philips
  50. 6.9.1 Philips Company Information
  51. 6.9.2 Philips Business Overview
  52. 6.9.3 Philips Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Philips Chronic Venous Insufficiency Product Portfolio
  54. 6.9.5 Philips Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Pfizer Chronic Venous Insufficiency Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 optimed Medizinische Instrumente
  62. 6.11.1 optimed Medizinische Instrumente Company Information
  63. 6.11.2 optimed Medizinische Instrumente Business Overview
  64. 6.11.3 optimed Medizinische Instrumente Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 optimed Medizinische Instrumente Chronic Venous Insufficiency Product Portfolio
  66. 6.11.5 optimed Medizinische Instrumente Recent Developments
  67. 6.12 Mylan
  68. 6.12.1 Mylan Company Information
  69. 6.12.2 Mylan Business Overview
  70. 6.12.3 Mylan Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Mylan Chronic Venous Insufficiency Product Portfolio
  72. 6.12.5 Mylan Recent Developments
  73. 6.13 Medtronic
  74. 6.13.1 Medtronic Company Information
  75. 6.13.2 Medtronic Business Overview
  76. 6.13.3 Medtronic Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Medtronic Chronic Venous Insufficiency Product Portfolio
  78. 6.13.5 Medtronic Recent Developments
  79. 6.14 Cook Ireland
  80. 6.14.1 Cook Ireland Company Information
  81. 6.14.2 Cook Ireland Business Overview
  82. 6.14.3 Cook Ireland Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Cook Ireland Chronic Venous Insufficiency Product Portfolio
  84. 6.14.5 Cook Ireland Recent Developments
  85. 6.15 Boston Scientific
  86. 6.15.1 Boston Scientific Company Information
  87. 6.15.2 Boston Scientific Business Overview
  88. 6.15.3 Boston Scientific Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Boston Scientific Chronic Venous Insufficiency Product Portfolio
  90. 6.15.5 Boston Scientific Recent Developments
  91. 6.16 BD(Angiomed)
  92. 6.16.1 BD(Angiomed) Company Information
  93. 6.16.2 BD(Angiomed) Business Overview
  94. 6.16.3 BD(Angiomed) Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 BD(Angiomed) Chronic Venous Insufficiency Product Portfolio
  96. 6.16.5 BD(Angiomed) Recent Developments
  97. 6.17 Allergan
  98. 6.17.1 Allergan Company Information
  99. 6.17.2 Allergan Business Overview
  100. 6.17.3 Allergan Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Allergan Chronic Venous Insufficiency Product Portfolio
  102. 6.17.5 Allergan Recent Developments
  103. 6.18 AbbVie
  104. 6.18.1 AbbVie Company Information
  105. 6.18.2 AbbVie Business Overview
  106. 6.18.3 AbbVie Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 AbbVie Chronic Venous Insufficiency Product Portfolio
  108. 6.18.5 AbbVie Recent Developments
  109. 6.19 Abbott
  110. 6.19.1 Abbott Company Information
  111. 6.19.2 Abbott Business Overview
  112. 6.19.3 Abbott Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Abbott Chronic Venous Insufficiency Product Portfolio
  114. 6.19.5 Abbott Recent Developments
  115. 6.20 3M
  116. 6.20.1 3M Company Information
  117. 6.20.2 3M Business Overview
  118. 6.20.3 3M Chronic Venous Insufficiency Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 3M Chronic Venous Insufficiency Product Portfolio
  120. 6.20.5 3M Recent Developments
7 North America
  1. 7.1 North America Chronic Venous Insufficiency Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Chronic Venous Insufficiency Market Size by Country (2021-2026)
  3. 7.3 North America Chronic Venous Insufficiency Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Chronic Venous Insufficiency Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Chronic Venous Insufficiency Market Size by Country (2021-2026)
  3. 8.3 Europe Chronic Venous Insufficiency Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Chronic Venous Insufficiency Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Chronic Venous Insufficiency Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Chronic Venous Insufficiency Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Chronic Venous Insufficiency Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Chronic Venous Insufficiency Market Size by Country (2021-2026)
  3. 10.3 South America Chronic Venous Insufficiency Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Chronic Venous Insufficiency Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Chronic Venous Insufficiency Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Chronic Venous Insufficiency Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst